Yang JL - Search Results

1

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Yao M, et al. Among authors: yang jl. World J Clin Cases. 2022 Apr 16;10(11):3321-3333. doi: 10.12998/wjcc.v10.i11.3321. World J Clin Cases. 2022. PMID: 35611205 Free PMC article. Review.

2

Peripheral nerve lesion induces an up-regulation of Spy1 in rat spinal cord.

Huang Y, Liu Y, Chen Y, Yu X, Yang J, Lu M, Lu Q, Ke Q, Shen A, Yan M. Huang Y, et al. Cell Mol Neurobiol. 2009 May;29(3):403-11. doi: 10.1007/s10571-008-9332-8. Epub 2008 Dec 10. Cell Mol Neurobiol. 2009. PMID: 19082704

3

Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in rats.

Dong ZZ, Yao DF, Wu W, Yao M, Yu HB, Shen JJ, Qiu LW, Yao NH, Sai WL, Yang JL. Dong ZZ, et al. Among authors: yang jl. Hepatobiliary Pancreat Dis Int. 2010 Apr;9(2):169-74. Hepatobiliary Pancreat Dis Int. 2010. PMID: 20382589

4

Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA.

Wu W, Yao D, Wang Y, Qiu L, Sai W, Yang J, Yao N, Li S, Bian Y, Wang Z, Yao D. Wu W, et al. Tumour Biol. 2010 Dec;31(6):605-11. doi: 10.1007/s13277-010-0076-y. Epub 2010 Jul 14. Tumour Biol. 2010. PMID: 20628843

5

[Effect of siRNA-mediated inhibition of nuclear transcription factor-kappa B on apoptosis of hepatocarcinoma cells].

Wang YL, Yao DF, Wu W, Sai WL, Qiu LW, Yang JL, Zhu JW. Wang YL, et al. Among authors: yang jl. Zhonghua Gan Zang Bing Za Zhi. 2010 Aug;18(8):609-13. doi: 10.3760/cma.j.issn.1007-3418.2010.08.014. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20825717 Chinese.

6

Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.

Yao M, Yao DF, Bian YZ, Zhang CG, Qiu LW, Wu W, Sai WL, Yang JL, Zhang HJ. Yao M, et al. Among authors: yang jl. Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):289-94. doi: 10.1016/s1499-3872(11)60048-9. Hepatobiliary Pancreat Dis Int. 2011. PMID: 21669573

7

[Abnormality of NF- kappa B expression and the clinical implications in patients with HBV-related hepatocellular carcinoma].

Wu W, Yao DF, Dong ZZ, Bian YZ, Yao NH, Qiu LW, Yang JL, Sai WL. Wu W, et al. Among authors: yang jl. Zhonghua Gan Zang Bing Za Zhi. 2011 Jun;19(6):466-8. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22053381 Chinese. No abstract available.

8

Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.

Yao M, Yao DF, Bian YZ, Wu W, Yan XD, Yu DD, Qiu LW, Yang JL, Zhang HJ, Sai WL, Chen J. Yao M, et al. Among authors: yang jl. Hepatobiliary Pancreat Dis Int. 2013 Apr;12(2):171-9. doi: 10.1016/s1499-3872(13)60028-4. Hepatobiliary Pancreat Dis Int. 2013. PMID: 23558072

9

Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.

Dong Z, Yao M, Wang L, Yang J, Yao D. Dong Z, et al. Mini Rev Med Chem. 2014;14(14):1183-93. doi: 10.2174/1389557515666150101105135. Mini Rev Med Chem. 2014. PMID: 25553423 Review.

10

Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.

Zhang H, Yao M, Wu W, Qiu L, Sai W, Yang J, Zheng W, Huang J, Yao D. Zhang H, et al. Tumour Biol. 2015 Dec;36(12):9373-83. doi: 10.1007/s13277-015-3678-6. Epub 2015 Jun 26. Tumour Biol. 2015. PMID: 26109000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,408 results

Search Page

Filters